BR9807299A - Vacina contra bursite infecciosa - Google Patents
Vacina contra bursite infecciosaInfo
- Publication number
- BR9807299A BR9807299A BR9807299-4A BR9807299A BR9807299A BR 9807299 A BR9807299 A BR 9807299A BR 9807299 A BR9807299 A BR 9807299A BR 9807299 A BR9807299 A BR 9807299A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- infectious
- infectious bursitis
- pouch
- size
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Patente de Invenção:<B>"VACINA CONTRA BURSITE INFECCIOSA"<D>. A presente invenção refere-se a uma vacina que é capaz de proteger aves domésticas contra infecções de bursite infecciosa, caracterizada pelo fato de que ela contém um vírus de bursite infecciosa que tem as propriedades combinadas quando da administração a uma galinha causando uma redução no tamanho do tamanho da bolsa, expresso como razão em peso bolsa/corpo, de menos de 55% e a capacidade de proteger as aves domésticas tendo um trato de anticorpo ELISA de pelo menos cerca de 500 e com vírus tendo as características acima.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97200298A EP0861665A1 (en) | 1997-02-03 | 1997-02-03 | Infectious bursitis vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9807299A true BR9807299A (pt) | 2000-04-18 |
BR9807299B1 BR9807299B1 (pt) | 2009-01-13 |
Family
ID=8227982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9807299-4A BR9807299B1 (pt) | 1997-02-03 | 1998-01-29 | vacina contra bursite infecciosa. |
Country Status (18)
Country | Link |
---|---|
US (1) | US7211260B1 (pt) |
EP (2) | EP0861665A1 (pt) |
JP (1) | JP2001511138A (pt) |
KR (1) | KR100545462B1 (pt) |
CN (1) | CN1178697C (pt) |
AR (1) | AR011108A1 (pt) |
AT (1) | ATE333894T1 (pt) |
AU (1) | AU745477B2 (pt) |
BR (1) | BR9807299B1 (pt) |
CA (1) | CA2278824A1 (pt) |
CO (1) | CO4790102A1 (pt) |
DE (1) | DE69835346T2 (pt) |
ES (1) | ES2268766T3 (pt) |
HK (1) | HK1024411A1 (pt) |
IL (1) | IL130832A (pt) |
NZ (1) | NZ336937A (pt) |
WO (1) | WO1998033522A1 (pt) |
ZA (1) | ZA98830B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0861665A1 (en) | 1997-02-03 | 1998-09-02 | Dimminaco Ag/Sa/Ltd. | Infectious bursitis vaccine |
ZA200104596B (en) | 2000-06-09 | 2001-12-06 | Akzo Nobel Nv | IBDV strain for in ovo administration. |
EP1161953A3 (en) * | 2000-06-09 | 2004-02-04 | Akzo Nobel N.V. | IBDV strain for in OVO administration |
ES2310062B1 (es) | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
KR101560793B1 (ko) | 2013-08-20 | 2015-10-15 | 주식회사 바이오포아 | 비병원성 전염성낭병 변이 바이러스 및 이의 백신으로써의 용도 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530831A (en) * | 1982-11-02 | 1985-07-23 | Akzo N.V. | Infectious Bursal Disease vaccine |
US4824668A (en) * | 1987-03-09 | 1989-04-25 | Sterwin Laboratories Inc. | Attenuated infectious bursal disease virus strain and vaccine therefrom |
US5192539A (en) * | 1988-07-21 | 1993-03-09 | Akzo N.V. | Infectious bursal disease virus production in continuous cell lines |
NZ235474A (en) * | 1989-10-18 | 1992-12-23 | Univ Maryland | Virus capable of inducing infectious bursal disease; assay and vaccine |
IL103939A (en) * | 1992-12-01 | 1996-09-12 | Abic Ltd | An anti-DBI vaccine in birds containing attenuated live DBI virus |
EP0861665A1 (en) | 1997-02-03 | 1998-09-02 | Dimminaco Ag/Sa/Ltd. | Infectious bursitis vaccine |
-
1997
- 1997-02-03 EP EP97200298A patent/EP0861665A1/en not_active Withdrawn
-
1998
- 1998-01-29 CN CNB988022346A patent/CN1178697C/zh not_active Expired - Fee Related
- 1998-01-29 AU AU62940/98A patent/AU745477B2/en not_active Ceased
- 1998-01-29 NZ NZ336937A patent/NZ336937A/en unknown
- 1998-01-29 US US09/355,374 patent/US7211260B1/en not_active Expired - Fee Related
- 1998-01-29 EP EP98906897A patent/EP0967991B1/en not_active Expired - Lifetime
- 1998-01-29 JP JP53252698A patent/JP2001511138A/ja not_active Ceased
- 1998-01-29 ES ES98906897T patent/ES2268766T3/es not_active Expired - Lifetime
- 1998-01-29 DE DE69835346T patent/DE69835346T2/de not_active Expired - Lifetime
- 1998-01-29 AT AT98906897T patent/ATE333894T1/de not_active IP Right Cessation
- 1998-01-29 WO PCT/EP1998/000461 patent/WO1998033522A1/en active IP Right Grant
- 1998-01-29 BR BRPI9807299-4A patent/BR9807299B1/pt not_active IP Right Cessation
- 1998-01-29 CA CA002278824A patent/CA2278824A1/en not_active Abandoned
- 1998-01-29 IL IL13083298A patent/IL130832A/xx not_active IP Right Cessation
- 1998-01-29 KR KR1019997006986A patent/KR100545462B1/ko not_active IP Right Cessation
- 1998-02-02 ZA ZA9800830A patent/ZA98830B/xx unknown
- 1998-02-02 CO CO98004888A patent/CO4790102A1/es unknown
- 1998-02-03 AR ARP980100475A patent/AR011108A1/es active IP Right Grant
-
2000
- 2000-06-21 HK HK00103768A patent/HK1024411A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU745477B2 (en) | 2002-03-21 |
BR9807299B1 (pt) | 2009-01-13 |
DE69835346D1 (de) | 2006-09-07 |
AU6294098A (en) | 1998-08-25 |
CO4790102A1 (es) | 1999-05-31 |
CN1246800A (zh) | 2000-03-08 |
DE69835346T2 (de) | 2006-11-23 |
HK1024411A1 (en) | 2000-10-13 |
IL130832A (en) | 2005-03-20 |
KR100545462B1 (ko) | 2006-01-24 |
ZA98830B (en) | 1999-08-02 |
EP0967991B1 (en) | 2006-07-26 |
ATE333894T1 (de) | 2006-08-15 |
EP0967991A1 (en) | 2000-01-05 |
KR20000070736A (ko) | 2000-11-25 |
IL130832A0 (en) | 2001-01-28 |
CA2278824A1 (en) | 1998-08-06 |
EP0861665A1 (en) | 1998-09-02 |
CN1178697C (zh) | 2004-12-08 |
JP2001511138A (ja) | 2001-08-07 |
NZ336937A (en) | 2001-10-26 |
US7211260B1 (en) | 2007-05-01 |
AR011108A1 (es) | 2000-08-02 |
WO1998033522A1 (en) | 1998-08-06 |
ES2268766T3 (es) | 2007-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY141594A (en) | 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES | |
BR9912410A (pt) | Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave | |
BR0208183A (pt) | Peptìdeo modificado por wt1 | |
BR9913681A (pt) | Composição farmacêutica compreendendo entacapona ou nitecapona, assim como um derivado de celulose reticulada | |
BR0214254A (pt) | Pó filmogênio micronizado e composição farmacêutica, cosmética ou neutracêutica | |
ATE295180T1 (de) | Zubereitung zur immunisierung gegen den aids- virus | |
BR0212374A (pt) | Oxintomodulina para a prevenção ou para o tratamento do excesso de peso | |
JP2008528512A5 (pt) | ||
RS20050066A (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
BR9810658A (pt) | Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna. | |
BR9807299A (pt) | Vacina contra bursite infecciosa | |
BR0013625A (pt) | Composição para uso no tratamento de carcinoma hepatocelular | |
BR9915429A (pt) | Haste de tampão. | |
BR0109139A (pt) | Composições farmacêuticas incluindo alginatos | |
BR0011261A (pt) | Composição oral compreendendo perlita, e, uso de perlita | |
BR0102940A (pt) | Agente para o tratamento de doença de parkinson compreendendo um agente de melhora da função de astrócitos como ingrediente ativo | |
Norton et al. | Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice | |
BRPI0713278A2 (pt) | agente profilÁtico ou terapÊutico para doenÇa viral | |
NZ228232A (en) | Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry | |
CO5170447A1 (es) | Derivado de benzamida y medicamento que lo contiene | |
TR200202169T1 (tr) | Tanı ve tedavide kullanım için pürifiye hepatit C virüsü zarf proteinleri. | |
ES2160927T3 (es) | Composiciones farmaceuticas que comprenden interferon alfa humano natural. | |
WO2004039402A3 (es) | Prevención y tratamiento del síndrome respiratorio y reproductivo del cerdo con el uso de immunoglobulinas obtenidas de la yema de huevo proveniente de gallinas hiperinmunizadas con el virus de prrs | |
KR940002268A (ko) | 21-클로로-프레그난 유도체 | |
ATE234861T1 (de) | Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
B24H | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi) | ||
B24F | Patent annual fee: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 14A, 15A, 16A, 17A, 18A, 19A, 20A, 21A E 22A ANUIDADES. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |